Prestige Consumer Healthcare Inc (NYSE:PBH) – Investment analysts at Jefferies Financial Group increased their FY2019 earnings per share (EPS) estimates for shares of Prestige Consumer Healthcare in a note issued to investors on Thursday, November 1st. Jefferies Financial Group analyst S. Wissink now expects that the company will earn $2.89 per share for the year, up from their prior forecast of $2.86. Jefferies Financial Group has a “Hold” rating and a $38.00 price target on the stock. Jefferies Financial Group also issued estimates for Prestige Consumer Healthcare’s Q1 2020 earnings at $0.68 EPS and Q2 2020 earnings at $0.73 EPS.
Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings data on Thursday, November 1st. The company reported $0.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.63 by $0.02. The firm had revenue of $239.36 million for the quarter, compared to analysts’ expectations of $236.28 million. Prestige Consumer Healthcare had a net margin of 33.38% and a return on equity of 11.82%. The company’s revenue for the quarter was down 7.2% compared to the same quarter last year. During the same quarter last year, the business posted $0.61 earnings per share.
Other equities research analysts have also recently issued research reports about the stock. Zacks Investment Research cut shares of Prestige Consumer Healthcare from a “hold” rating to a “strong sell” rating in a research report on Tuesday, July 10th. DA Davidson lifted their price objective on shares of Prestige Consumer Healthcare to $38.00 and gave the company a “neutral” rating in a research report on Monday. Finally, ValuEngine upgraded shares of Prestige Consumer Healthcare from a “strong sell” rating to a “sell” rating in a research report on Thursday, October 11th. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and four have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $72.40.
Prestige Consumer Healthcare stock opened at $40.58 on Monday. The company has a market cap of $1.95 billion, a PE ratio of 15.73, a P/E/G ratio of 1.87 and a beta of 1.04. The company has a current ratio of 2.15, a quick ratio of 1.38 and a debt-to-equity ratio of 1.59. Prestige Consumer Healthcare has a 1 year low of $27.84 and a 1 year high of $48.24.
Several hedge funds have recently bought and sold shares of the stock. Raymond James & Associates boosted its stake in Prestige Consumer Healthcare by 36.1% during the second quarter. Raymond James & Associates now owns 45,163 shares of the company’s stock worth $1,733,000 after buying an additional 11,989 shares during the period. Janus Henderson Group PLC boosted its stake in Prestige Consumer Healthcare by 10.4% during the second quarter. Janus Henderson Group PLC now owns 943,042 shares of the company’s stock worth $36,194,000 after buying an additional 88,822 shares during the period. Flinton Capital Management LLC boosted its stake in Prestige Consumer Healthcare by 32.0% during the second quarter. Flinton Capital Management LLC now owns 31,776 shares of the company’s stock worth $1,220,000 after buying an additional 7,696 shares during the period. Dimensional Fund Advisors LP boosted its stake in Prestige Consumer Healthcare by 37.7% during the second quarter. Dimensional Fund Advisors LP now owns 3,199,714 shares of the company’s stock worth $122,805,000 after buying an additional 876,192 shares during the period. Finally, Dalton Greiner Hartman Maher & Co. purchased a new position in Prestige Consumer Healthcare during the third quarter worth $16,851,000.
About Prestige Consumer Healthcare
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.
See Also: Fundamental Analysis
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.